The CD31-positive areas were 10863 ± 1762 μm2 in untreated HCC livers versus 6589 ± 738 μm2 in rosuvastatin-treated HCC (P < .05) (Figure 2(c)). Here, PECAM1 is linked to hepatocellular carcinoma.